The overall incidence of peripheral neuropathy was 43.6% in the polatuzumab vedotin + BR arm compared with 7.7% in the…
HDAC Inhibitor
The overall incidence of peripheral neuropathy was 43.6% in the polatuzumab vedotin + BR arm compared with 7.7% in the…